PHARMACOKINETICS OF PIRAZOLAC - A NEW ANTI-INFLAMMATORY DRUG IN HUMAN VOLUNTEERS .1. ABSORPTION, DISPOSITION, BIOTRANSFORMATION AND EXCRETION

被引：8

作者：

TAUBER, U

WEISS, C

KRAUSE, W

ACKSTEINER, B

MATTHES, H

机构：

来源：

EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS | 1985年 / 10卷 / 01期

关键词：

D O I：

10.1007/BF03189696

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：41 / 53

页数：13

共 8 条

[1]

BACHMANN F, 1980, BIOL MED, V2, P153

[2]

BIERE H, 1982, EUR J MED CHEM, V17, P27

[3] PROGRAM LIBRARY FOR COMPUTING THE PARAMETERS OF LINEAR COMPARTMENT MODELS IN PHARMACOKINETICS [J].

POLAND, H ;

WOLOSZCZAK, R .

INTERNATIONAL JOURNAL OF BIO-MEDICAL COMPUTING, 1980, 11 (02) :115-128

[4]

SPECK U, 1976, CONTRACEPTION, V14, P152

[5]

TAUBER U, UNPUB DETERMINATION

[6]

TAUBER U, 1985, PHARM RES, V4

[7] CLINICAL PHARMACOKINETICS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS [J].

VERBEECK, RK ;

BLACKBURN, JL ;

LOEWEN, GR .

CLINICAL PHARMACOKINETICS, 1983, 8 (04) :297-331

[8] PHARMACOKINETICS OF DICLOFENAC SODIUM FOLLOWING INTRAVENOUS AND ORAL-ADMINISTRATION [J].

WILLIS, JV ;

KENDALL, MJ ;

FLINN, RM ;

THORNHILL, DP ;

WELLING, PG .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (06) :405-410

← 1 →